FDA OKs new microfabricated bone grafts

March 24, 2004 — Therics Inc. has received clearance from the U.S. Food and Drug Administration to sell a new microfabricated bone void filler for skeletal defects, according to a news release.


The extensions covered by the FDA clearance complete a new line of bone graft products offered by the Princeton, N.J.-based firm. The products feature a design of calcium salt that creates an interlocking network within the bone defect to promote healing.


Therics a subsidiary of Tredegar Corp. , has licensed its microfabrication processes from the Massachusetts Institute of Technology.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.